share_log

健民集团(600976.SH)：公司在研产品通降颗粒二期临床试验已处于总结阶段

Jianmin Group (600976.SH): The phase II clinical trial of the company's product Tongzheng Granule is in the summary stage

Gelonghui Finance ·  Apr 16 17:53

Gelonghui April 16 丨 Some investors asked Jianmin Group (600976.SH) through an interactive platform: How is your company's clinical progress in Tongzheng Granule? How long until launch?

Jianmin Group (600976.SH) replied: The second phase clinical trial of the company's product Tongzheng Granule is in the summary stage. There is some uncertainty in the development of new drugs. Investors are kindly requested to pay attention to investment risks.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment